United States Biotechnology & Medical Research

Ardelyx, Inc. (ARDX)

Ardelyx, Inc. experienced significant insider selling over the past ninety days, totaling approximately $1.01 million across twenty-nine transactions. Eight executives offloaded shares, contributing to a net negative value of $486,197. This activity coincides with a twenty-eight percent decline in stock price, occurring prior to the most recent November earnings report.
Ticker: ARDX Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Ardelyx, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.9
Hohenleitner Susan Chief Financial Officer Officer
Transaction date
Sale
Price
90.18
Quantity 83,600 -40.8%
Value US$664,465
2.5
Reilly Joseph James See Remarks Officer
Transaction date
Sale
Price
226.06
Quantity 70,499 -13.5%
Value US$3,418,092
2.5
Reilly Joseph James See Remarks Officer
Transaction date
Sale
Price
338.49
Quantity 81,338 +44.8%
Value US$1,976,027
3.0
Brady James Parker Chief Human Resources Officer Officer
Transaction date
Sale
Price
3.86
Quantity 13,160 -5.1%
Value US$50,757
3.0
Brady James Parker Chief Human Resources Officer Officer
Transaction date
Sale
Price
3.86
Quantity 1,976 -0.8%
Value US$7,621
3.1
Foster Eric Duane Chief Commercial Officer Officer
Transaction date
Sale
Price
3.86
Quantity 2,575 -0.6%
Value US$9,932
3.1
Foster Eric Duane Chief Commercial Officer Officer
Transaction date
Sale
Price
3.86
Quantity 3,389 -0.8%
Value US$13,071
3.1
Foster Eric Duane Chief Commercial Officer Officer
Transaction date
Sale
Price
3.86
Quantity 2,598 -0.6%
Value US$10,020
3.0
Bishop John E See Remarks Officer
Transaction date
Sale
Price
3.86
Quantity 2,469 -0.8%
Value US$9,523
3.0
Bishop John E See Remarks Officer
Transaction date
Sale
Price
3.86
Quantity 17,281 -5.1%
Value US$66,651
2.8
Kelliher Mike Chief Business Officer Officer
Transaction date
Sale
Price
3.86
Quantity 2,002 -0.6%
Value US$7,722
2.8
Kelliher Mike Chief Business Officer Officer
Transaction date
Sale
Price
3.86
Quantity 2,652 -0.7%
Value US$10,228
2.8
Kelliher Mike Chief Business Officer Officer
Transaction date
Sale
Price
3.86
Quantity 3,104 -0.9%
Value US$11,972
3.8
Williams Laura A Chief Patient Officer Officer
Transaction date
Sale
Price
3.86
Quantity 1,734 -0.5%
Value US$6,688
3.8
Williams Laura A Chief Patient Officer Officer
Transaction date
Sale
Price
3.86
Quantity 2,430 -0.7%
Value US$9,372
3.8
Williams Laura A Chief Patient Officer Officer
Transaction date
Sale
Price
3.86
Quantity 3,089 -0.8%
Value US$11,914
3.8
Williams Laura A Chief Patient Officer Officer
Transaction date
Sale
Price
3.86
Quantity 3,486 -0.9%
Value US$13,445
3.4
RAAB MICHAEL President & CEO Executive Director
Transaction date
Sale
Price
3.86
Quantity 19,178 -1.2%
Value US$73,968
3.4
RAAB MICHAEL President & CEO Executive Director
Transaction date
Sale
Price
3.86
Quantity 8,411 -0.5%
Value US$32,440
3.4
RAAB MICHAEL President & CEO Executive Director
Transaction date
Sale
Price
3.86
Quantity 15,976 -1.0%
Value US$61,618
3.4
RAAB MICHAEL President & CEO Executive Director
Transaction date
Sale
Price
3.86
Quantity 15,009 -0.9%
Value US$57,888
2.9
Hohenleitner Susan Officer Officer
Transaction date
Proposed sale
Price
4.03
Quantity 2,650
Value US$10,680
2.8
Kelliher Mike Officer Officer
Transaction date
Proposed sale
Price
4.03
Quantity 10,500
Value US$42,315
3.4
RAAB MICHAEL Officer Officer
Transaction date
Proposed sale
Price
4.03
Quantity 44,500
Value US$179,335
3.8
Williams Laura A Officer Officer
Transaction date
Proposed sale
Price
4.03
Quantity 10,500
Value US$42,315
2.5
Reilly Joseph James Officer Officer
Transaction date
Proposed sale
Price
4.03
Quantity 4,700
Value US$18,941
3.0
Bishop John E Officer Officer
Transaction date
Proposed sale
Price
4.03
Quantity 25,500
Value US$102,765
3.0
Brady James Parker Officer Officer
Transaction date
Proposed sale
Price
4.03
Quantity 19,700
Value US$79,391
3.1
Foster Eric Duane Officer Officer
Transaction date
Proposed sale
Price
4.03
Quantity 11,900
Value US$47,957
3.4
RAAB MICHAEL President & CEO Executive Director
Transaction date
Planned sale
Price
5.06
Quantity 41,668 -2.4%
Value US$210,923
3.8
Williams Laura A Chief Patient Officer Officer
Transaction date
Planned sale
Price
5.99
Quantity 81,898 -17.8%
Value US$490,487
3.8
Williams Laura A Chief Patient Officer Officer
Transaction date
Planned sale
Price
5.99
Quantity 81,898 -17.8%
Value US$490,487
3.8
LAURA WILLIAMS Officer Officer
Transaction date
Proposed sale
Price
5.84
Quantity 81,898
Value US$478,284
3.4
RAAB MICHAEL President & CEO Executive Director
Transaction date
Planned sale
Price
5.67
Quantity 41,666 -2.4%
Value US$236,346
3.4
RAAB MICHAEL Officer; Director Executive Director
Transaction date
Proposed sale
Price
5.68
Quantity 41,666
Value US$236,663
3.4
MICHAEL RAAB Director; Officer Executive Director
Transaction date
Proposed sale
Price
5.69
Quantity 125,000
Value US$711,250
3.1
Foster Eric Duane Chief Commercial Officer Officer
Transaction date
Sale
Price
6.27
Quantity 2,405 -0.6%
Value US$15,073
3.1
Foster Eric Duane Chief Commercial Officer Officer
Transaction date
Sale
Price
6.27
Quantity 2,427 -0.6%
Value US$15,211
3.1
Foster Eric Duane Chief Commercial Officer Officer
Transaction date
Sale
Price
6.27
Quantity 3,166 -0.7%
Value US$19,843
3.4
RAAB MICHAEL President & CEO Executive Director
Transaction date
Sale
Price
6.27
Quantity 14,028 -0.8%
Value US$87,920
3.4
RAAB MICHAEL President & CEO Executive Director
Transaction date
Sale
Price
6.27
Quantity 17,926 -1.0%
Value US$112,351
3.4
RAAB MICHAEL President & CEO Executive Director
Transaction date
Sale
Price
6.27
Quantity 7,861 -0.4%
Value US$49,269
3.4
RAAB MICHAEL President & CEO Executive Director
Transaction date
Sale
Price
6.27
Quantity 14,933 -0.8%
Value US$93,593
2.8
Kelliher Mike Chief Business Officer Officer
Transaction date
Sale
Price
6.27
Quantity 2,478 -0.7%
Value US$15,531
2.8
Kelliher Mike Chief Business Officer Officer
Transaction date
Sale
Price
6.27
Quantity 1,870 -0.5%
Value US$11,720
2.8
Kelliher Mike Chief Business Officer Officer
Transaction date
Sale
Price
6.27
Quantity 2,900 -0.8%
Value US$18,176
3.8
Williams Laura A Chief Patient Officer Officer
Transaction date
Sale
Price
6.27
Quantity 1,418 -0.3%
Value US$8,887
3.8
Williams Laura A Chief Patient Officer Officer
Transaction date
Sale
Price
6.27
Quantity 1,911 -0.4%
Value US$11,977
3.8
Williams Laura A Chief Patient Officer Officer
Transaction date
Sale
Price
6.27
Quantity 2,157 -0.5%
Value US$13,519
3.8
Williams Laura A Chief Patient Officer Officer
Transaction date
Sale
Price
6.27
Quantity 1,503 -0.3%
Value US$9,420
2.9
Hohenleitner Susan Chief Financial Officer Officer
Transaction date
Sale
Price
6.27
Quantity 1,455 -0.6%
Value US$9,119
3.0
Brady James Parker Chief Human Resources Officer Officer
Transaction date
Sale
Price
6.27
Quantity 1,846 -0.7%
Value US$11,570
2.5
Reilly Joseph James See Remarks Officer
Transaction date
Planned sale
Price
6.27
Quantity 1,036 -0.7%
Value US$6,493
2.5
Reilly Joseph James See Remarks Officer
Transaction date
Sale
Price
6.27
Quantity 2,683 -1.8%
Value US$16,816
3.0
Bishop John E See Remarks Officer
Transaction date
Sale
Price
6.27
Quantity 2,306 -0.7%
Value US$14,453
2.8
Kelliher Mike Officer Officer
Transaction date
Proposed sale
Price
6.23
Quantity 10,500
Value US$65,415
3.0
Brady James Parker Officer Officer
Transaction date
Proposed sale
Price
6.23
Quantity 3,000
Value US$18,690
3.1
Foster Eric Duane Officer Officer
Transaction date
Proposed sale
Price
6.23
Quantity 11,900
Value US$74,137
2.5
Reilly Joseph James Officer Officer
Transaction date
Proposed sale
Price
6.23
Quantity 4,700
Value US$29,281
2.9
Hohenleitner Susan Officer Officer
Transaction date
Proposed sale
Price
6.23
Quantity 2,650
Value US$16,510
3.8
Williams Laura A Officer Officer
Transaction date
Proposed sale
Price
6.23
Quantity 10,500
Value US$65,415
3.4
RAAB MICHAEL Officer Officer
Transaction date
Proposed sale
Price
6.23
Quantity 44,500
Value US$277,235
3.0
Bishop John E Officer Officer
Transaction date
Proposed sale
Price
6.23
Quantity 3,700
Value US$23,051
3.4
RAAB MICHAEL President & CEO Executive Director
Transaction date
Planned sale
Price
6.28
Quantity 41,666 -2.3%
Value US$261,612
3.4
RAAB MICHAEL President & CEO Executive Director
Transaction date
Planned sale
Price
6.29
Quantity 41,668 -2.3%
Value US$261,954
3.4
RAAB MICHAEL President & CEO Executive Director
Transaction date
Planned sale
Price
5.84
Quantity 41,666 -2.2%
Value US$243,329
3.4
RAAB MICHAEL President & CEO Executive Director
Transaction date
Planned sale
Price
6.26
Quantity 41,666 -2.2%
Value US$260,621
3.4
MICHAEL RAAB Director; Officer Executive Director
Transaction date
Proposed sale
Price
5.75
Quantity 166,666
Value US$958,330
4.0
MOTT DAVID M Non-Executive Director
Transaction date
Purchase
Price
5.84
Quantity 333,333 +11.2%
Value US$1,946,331
2.5
Reilly Joseph James See Remarks Officer
Transaction date
Sale
Price
5.70
Quantity 2 -0.0%
Value US$11
2.5
Reilly Joseph James See Remarks Officer
Transaction date
Sale
Price
5.71
Quantity 602 -0.4%
Value US$3,440
2.5
Reilly Joseph James See Remarks Officer
Transaction date
Sale
Price
5.87
Quantity 4,387 -2.8%
Value US$25,730
3.0
Bishop John E See Remarks Officer
Transaction date
Sale
Price
5.70
Quantity 1 -0.0%
Value US$6
3.0
Bishop John E See Remarks Officer
Transaction date
Sale
Price
5.71
Quantity 386 -0.1%
Value US$2,206
3.0
Bishop John E See Remarks Officer
Transaction date
Sale
Price
5.87
Quantity 2,792 -0.8%
Value US$16,375
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-25 2026-08-21 S Sale
2.9
Hohenleitner Susan

Chief Financial Officer

Officer
83,600 -40.8%
90.18
US$664,465 		83,600 -40.8% 90.18 US$664,465
2026-08-25 2026-08-21 S Sale
2.5
Reilly Joseph James

See Remarks

Officer
70,499 -13.5%
226.06
US$3,418,092 		70,499 -13.5% 226.06 US$3,418,092
2026-08-25 2026-08-21 S Sale
2.5
Reilly Joseph James

See Remarks

Officer
81,338 +44.8%
338.49
US$1,976,027 		81,338 +44.8% 338.49 US$1,976,027
2026-08-25 2026-08-21 S Sale
3.0
Brady James Parker

Chief Human Resources Officer

Officer
13,160 -5.1%
3.86
US$50,757 		13,160 -5.1% 3.86 US$50,757
2026-08-25 2026-08-21 S Sale
3.0
Brady James Parker

Chief Human Resources Officer

Officer
1,976 -0.8%
3.86
US$7,621 		1,976 -0.8% 3.86 US$7,621
2026-08-25 2026-08-21 S Sale
3.1
Foster Eric Duane

Chief Commercial Officer

Officer
2,575 -0.6%
3.86
US$9,932 		2,575 -0.6% 3.86 US$9,932
2026-08-25 2026-08-21 S Sale
3.1
Foster Eric Duane

Chief Commercial Officer

Officer
3,389 -0.8%
3.86
US$13,071 		3,389 -0.8% 3.86 US$13,071
2026-08-25 2026-08-21 S Sale
3.1
Foster Eric Duane

Chief Commercial Officer

Officer
2,598 -0.6%
3.86
US$10,020 		2,598 -0.6% 3.86 US$10,020
2026-08-25 2026-08-21 S Sale
3.0
Bishop John E

See Remarks

Officer
2,469 -0.8%
3.86
US$9,523 		2,469 -0.8% 3.86 US$9,523
2026-08-25 2026-08-21 S Sale
3.0
Bishop John E

See Remarks

Officer
17,281 -5.1%
3.86
US$66,651 		17,281 -5.1% 3.86 US$66,651
2026-08-25 2026-08-21 S Sale
2.8
Kelliher Mike

Chief Business Officer

Officer
2,002 -0.6%
3.86
US$7,722 		2,002 -0.6% 3.86 US$7,722
2026-08-25 2026-08-21 S Sale
2.8
Kelliher Mike

Chief Business Officer

Officer
2,652 -0.7%
3.86
US$10,228 		2,652 -0.7% 3.86 US$10,228
2026-08-25 2026-08-21 S Sale
2.8
Kelliher Mike

Chief Business Officer

Officer
3,104 -0.9%
3.86
US$11,972 		3,104 -0.9% 3.86 US$11,972
2026-08-25 2026-08-21 S Sale
3.8
Williams Laura A

Chief Patient Officer

Officer
1,734 -0.5%
3.86
US$6,688 		1,734 -0.5% 3.86 US$6,688
2026-08-25 2026-08-21 S Sale
3.8
Williams Laura A

Chief Patient Officer

Officer
2,430 -0.7%
3.86
US$9,372 		2,430 -0.7% 3.86 US$9,372
2026-08-25 2026-08-21 S Sale
3.8
Williams Laura A

Chief Patient Officer

Officer
3,089 -0.8%
3.86
US$11,914 		3,089 -0.8% 3.86 US$11,914
2026-08-25 2026-08-21 S Sale
3.8
Williams Laura A

Chief Patient Officer

Officer
3,486 -0.9%
3.86
US$13,445 		3,486 -0.9% 3.86 US$13,445
2026-08-25 2026-08-21 S Sale
3.4
RAAB MICHAEL

President & CEO

Executive Director
19,178 -1.2%
3.86
US$73,968 		19,178 -1.2% 3.86 US$73,968
2026-08-25 2026-08-21 S Sale
3.4
RAAB MICHAEL

President & CEO

Executive Director
8,411 -0.5%
3.86
US$32,440 		8,411 -0.5% 3.86 US$32,440
2026-08-25 2026-08-21 S Sale
3.4
RAAB MICHAEL

President & CEO

Executive Director
15,976 -1.0%
3.86
US$61,618 		15,976 -1.0% 3.86 US$61,618
2026-08-25 2026-08-21 S Sale
3.4
RAAB MICHAEL

President & CEO

Executive Director
15,009 -0.9%
3.86
US$57,888 		15,009 -0.9% 3.86 US$57,888
2026-08-21 2026-08-21 PrS Proposed sale
2.9
Hohenleitner Susan

Officer

Officer
2,650
4.03
US$10,680 		2,650 4.03 US$10,680
2026-08-21 2026-08-21 PrS Proposed sale
2.8
Kelliher Mike

Officer

Officer
10,500
4.03
US$42,315 		10,500 4.03 US$42,315
2026-08-21 2026-08-21 PrS Proposed sale
3.4
RAAB MICHAEL

Officer

Officer
44,500
4.03
US$179,335 		44,500 4.03 US$179,335
2026-08-21 2026-08-21 PrS Proposed sale
3.8
Williams Laura A

Officer

Officer
10,500
4.03
US$42,315 		10,500 4.03 US$42,315
2026-08-21 2026-08-21 PrS Proposed sale
2.5
Reilly Joseph James

Officer

Officer
4,700
4.03
US$18,941 		4,700 4.03 US$18,941
2026-08-21 2026-08-21 PrS Proposed sale
3.0
Bishop John E

Officer

Officer
25,500
4.03
US$102,765 		25,500 4.03 US$102,765
2026-08-21 2026-08-21 PrS Proposed sale
3.0
Brady James Parker

Officer

Officer
19,700
4.03
US$79,391 		19,700 4.03 US$79,391
2026-08-21 2026-08-21 PrS Proposed sale
3.1
Foster Eric Duane

Officer

Officer
11,900
4.03
US$47,957 		11,900 4.03 US$47,957
2026-07-17 2026-07-15 PlS Planned sale
3.4
RAAB MICHAEL

President & CEO

Executive Director
41,668 -2.4%
5.06
US$210,923 		41,668 -2.4% 5.06 US$210,923
2026-06-22 2026-06-18 PlS Planned sale
3.8
Williams Laura A

Chief Patient Officer

Officer
81,898 -17.8%
5.99
US$490,487 		81,898 -17.8% 5.99 US$490,487
2026-06-22 2026-06-18 PlS Planned sale
3.8
Williams Laura A

Chief Patient Officer

Officer
81,898 -17.8%
5.99
US$490,487 		81,898 -17.8% 5.99 US$490,487
2026-06-18 2026-06-18 PrS Proposed sale
3.8
LAURA WILLIAMS

Officer

Officer
81,898
5.84
US$478,284 		81,898 5.84 US$478,284
2026-06-17 2026-06-15 PlS Planned sale
3.4
RAAB MICHAEL

President & CEO

Executive Director
41,666 -2.4%
5.67
US$236,346 		41,666 -2.4% 5.67 US$236,346
2026-06-17 2026-06-15 PrS Proposed sale
3.4
RAAB MICHAEL

Officer; Director

Executive Director
41,666
5.68
US$236,663 		41,666 5.68 US$236,663
2026-06-15 2026-06-15 PrS Proposed sale
3.4
MICHAEL RAAB

Director; Officer

Executive Director
125,000
5.69
US$711,250 		125,000 5.69 US$711,250
2026-05-22 2026-05-21 S Sale
3.1
Foster Eric Duane

Chief Commercial Officer

Officer
2,405 -0.6%
6.27
US$15,073 		2,405 -0.6% 6.27 US$15,073
2026-05-22 2026-05-21 S Sale
3.1
Foster Eric Duane

Chief Commercial Officer

Officer
2,427 -0.6%
6.27
US$15,211 		2,427 -0.6% 6.27 US$15,211
2026-05-22 2026-05-21 S Sale
3.1
Foster Eric Duane

Chief Commercial Officer

Officer
3,166 -0.7%
6.27
US$19,843 		3,166 -0.7% 6.27 US$19,843
2026-05-22 2026-05-21 S Sale
3.4
RAAB MICHAEL

President & CEO

Executive Director
14,028 -0.8%
6.27
US$87,920 		14,028 -0.8% 6.27 US$87,920
2026-05-22 2026-05-21 S Sale
3.4
RAAB MICHAEL

President & CEO

Executive Director
17,926 -1.0%
6.27
US$112,351 		17,926 -1.0% 6.27 US$112,351
2026-05-22 2026-05-21 S Sale
3.4
RAAB MICHAEL

President & CEO

Executive Director
7,861 -0.4%
6.27
US$49,269 		7,861 -0.4% 6.27 US$49,269
2026-05-22 2026-05-21 S Sale
3.4
RAAB MICHAEL

President & CEO

Executive Director
14,933 -0.8%
6.27
US$93,593 		14,933 -0.8% 6.27 US$93,593
2026-05-22 2026-05-21 S Sale
2.8
Kelliher Mike

Chief Business Officer

Officer
2,478 -0.7%
6.27
US$15,531 		2,478 -0.7% 6.27 US$15,531
2026-05-22 2026-05-21 S Sale
2.8
Kelliher Mike

Chief Business Officer

Officer
1,870 -0.5%
6.27
US$11,720 		1,870 -0.5% 6.27 US$11,720
2026-05-22 2026-05-21 S Sale
2.8
Kelliher Mike

Chief Business Officer

Officer
2,900 -0.8%
6.27
US$18,176 		2,900 -0.8% 6.27 US$18,176
2026-05-22 2026-05-21 S Sale
3.8
Williams Laura A

Chief Patient Officer

Officer
1,418 -0.3%
6.27
US$8,887 		1,418 -0.3% 6.27 US$8,887
2026-05-22 2026-05-21 S Sale
3.8
Williams Laura A

Chief Patient Officer

Officer
1,911 -0.4%
6.27
US$11,977 		1,911 -0.4% 6.27 US$11,977
2026-05-22 2026-05-21 S Sale
3.8
Williams Laura A

Chief Patient Officer

Officer
2,157 -0.5%
6.27
US$13,519 		2,157 -0.5% 6.27 US$13,519
2026-05-22 2026-05-21 S Sale
3.8
Williams Laura A

Chief Patient Officer

Officer
1,503 -0.3%
6.27
US$9,420 		1,503 -0.3% 6.27 US$9,420
2026-05-22 2026-05-21 S Sale
2.9
Hohenleitner Susan

Chief Financial Officer

Officer
1,455 -0.6%
6.27
US$9,119 		1,455 -0.6% 6.27 US$9,119
2026-05-22 2026-05-21 S Sale
3.0
Brady James Parker

Chief Human Resources Officer

Officer
1,846 -0.7%
6.27
US$11,570 		1,846 -0.7% 6.27 US$11,570
2026-05-22 2026-05-21 PlS Planned sale
2.5
Reilly Joseph James

See Remarks

Officer
1,036 -0.7%
6.27
US$6,493 		1,036 -0.7% 6.27 US$6,493
2026-05-22 2026-05-21 S Sale
2.5
Reilly Joseph James

See Remarks

Officer
2,683 -1.8%
6.27
US$16,816 		2,683 -1.8% 6.27 US$16,816
2026-05-22 2026-05-21 S Sale
3.0
Bishop John E

See Remarks

Officer
2,306 -0.7%
6.27
US$14,453 		2,306 -0.7% 6.27 US$14,453
2026-05-19 2026-05-19 PrS Proposed sale
2.8
Kelliher Mike

Officer

Officer
10,500
6.23
US$65,415 		10,500 6.23 US$65,415
2026-05-19 2026-05-19 PrS Proposed sale
3.0
Brady James Parker

Officer

Officer
3,000
6.23
US$18,690 		3,000 6.23 US$18,690
2026-05-19 2026-05-19 PrS Proposed sale
3.1
Foster Eric Duane

Officer

Officer
11,900
6.23
US$74,137 		11,900 6.23 US$74,137
2026-05-19 2026-05-19 PrS Proposed sale
2.5
Reilly Joseph James

Officer

Officer
4,700
6.23
US$29,281 		4,700 6.23 US$29,281
2026-05-19 2026-05-19 PrS Proposed sale
2.9
Hohenleitner Susan

Officer

Officer
2,650
6.23
US$16,510 		2,650 6.23 US$16,510
2026-05-19 2026-05-19 PrS Proposed sale
3.8
Williams Laura A

Officer

Officer
10,500
6.23
US$65,415 		10,500 6.23 US$65,415
2026-05-19 2026-05-19 PrS Proposed sale
3.4
RAAB MICHAEL

Officer

Officer
44,500
6.23
US$277,235 		44,500 6.23 US$277,235
2026-05-19 2026-05-19 PrS Proposed sale
3.0
Bishop John E

Officer

Officer
3,700
6.23
US$23,051 		3,700 6.23 US$23,051
2026-05-19 2026-05-15 PlS Planned sale
3.4
RAAB MICHAEL

President & CEO

Executive Director
41,666 -2.3%
6.28
US$261,612 		41,666 -2.3% 6.28 US$261,612
2026-04-17 2026-04-15 PlS Planned sale
3.4
RAAB MICHAEL

President & CEO

Executive Director
41,668 -2.3%
6.29
US$261,954 		41,668 -2.3% 6.29 US$261,954
2026-03-18 2026-03-16 PlS Planned sale
3.4
RAAB MICHAEL

President & CEO

Executive Director
41,666 -2.2%
5.84
US$243,329 		41,666 -2.2% 5.84 US$243,329
2026-02-25 2026-02-24 PlS Planned sale
3.4
RAAB MICHAEL

President & CEO

Executive Director
41,666 -2.2%
6.26
US$260,621 		41,666 -2.2% 6.26 US$260,621
2026-02-24 2026-02-24 PrS Proposed sale
3.4
MICHAEL RAAB

Director; Officer

Executive Director
166,666
5.75
US$958,330 		166,666 5.75 US$958,330
2026-02-23 2026-02-20 B Purchase
4.0
MOTT DAVID M
Non-Executive Director
333,333 +11.2%
5.84
US$1,946,331 		333,333 +11.2% 5.84 US$1,946,331
2026-02-23 2026-02-20 S Sale
2.5
Reilly Joseph James

See Remarks

Officer
2 -0.0%
5.70
US$11 		2 -0.0% 5.70 US$11
2026-02-23 2026-02-20 S Sale
2.5
Reilly Joseph James

See Remarks

Officer
602 -0.4%
5.71
US$3,440 		602 -0.4% 5.71 US$3,440
2026-02-23 2026-02-20 S Sale
2.5
Reilly Joseph James

See Remarks

Officer
4,387 -2.8%
5.87
US$25,730 		4,387 -2.8% 5.87 US$25,730
2026-02-23 2026-02-20 S Sale
3.0
Bishop John E

See Remarks

Officer
1 -0.0%
5.70
US$6 		1 -0.0% 5.70 US$6
2026-02-23 2026-02-20 S Sale
3.0
Bishop John E

See Remarks

Officer
386 -0.1%
5.71
US$2,206 		386 -0.1% 5.71 US$2,206
2026-02-23 2026-02-20 S Sale
3.0
Bishop John E

See Remarks

Officer
2,792 -0.8%
5.87
US$16,375 		2,792 -0.8% 5.87 US$16,375

See older Ardelyx, Inc. insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock Ardelyx, Inc. history with Plus

Billed monthly · Cancel anytime

Explore more

More insider trading research around Ardelyx, Inc.

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America